SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.

Abou Hassan, Ossama K; Sheng, Calvin C; Wang, Tom Kai Ming; Cremer, Paul C

Abou Hassan, Ossama K; Sheng, Calvin C; Wang, Tom Kai Ming; Cremer, Paul C.

Afiliação

Abou Hassan OK; Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Sheng CC; Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Wang TKM; Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Cremer PC; Section of Cardiovascular Imaging, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, 44195, USA. cremerp@ccf.org.

Curr Cardiol Rep ; 23(9): 129, 2021 08 03.

Article em En | MEDLINE | ID: mdl-34342728

Assuntos

COVID-19; Miocardite; Células Endoteliais; Humanos; Incidência; Miocardite/diagnóstico; Miocardite/epidemiologia; Miocardite/terapia; Prognóstico; RNA Viral; SARS-CoV-2

Palavras-chave

COVID-19; COVID-19 therapy; Myocardial injury; Myocarditis; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Miocardite Tipo de estudo: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google